PPF Group Amends Autolus Therapeutics Stake Filing

Ticker: AUTL · Form: SC 13D/A · Filed: 2024-10-25T00:00:00.000Z

Sentiment: neutral

Topics: schedule-13d, amendment, shareholder-filing

Related Tickers: AUTL

TL;DR

PPF Group updated their Autolus Therapeutics stake filing on 10/25/24. Watch for potential moves.

AI Summary

PPF Group N.V. and its affiliates, including AMALAR HOLDING S.R.O. and RENATA KELLNEROVA, filed an amendment to their Schedule 13D on October 25, 2024, regarding their holdings in Autolus Therapeutics plc. This filing indicates a change in their beneficial ownership of the company's American Depositary Shares and ordinary shares.

Why It Matters

This amendment signals a potential shift in significant shareholder activity for Autolus Therapeutics, which could influence the company's stock performance and strategic direction.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings by major shareholders like PPF Group can indicate strategic shifts or potential future actions that may impact the stock price.

Key Players & Entities

FAQ

What specific changes were made in Amendment No. 10 to the Schedule 13D?

The filing is an amendment to a Schedule 13D, indicating a change in the information previously reported regarding beneficial ownership of Autolus Therapeutics plc securities.

Who are the primary entities involved in this filing?

The primary entities are PPF Group N.V. and its group members AMALAR HOLDING S.R.O. and RENATA KELLNEROVA, filing concerning Autolus Therapeutics plc.

What is the CUSIP number for the securities in question?

The CUSIP number for the American Depositary Shares and ordinary shares of Autolus Therapeutics plc is 05280R100.

When was this amendment filed with the SEC?

This amendment was filed on October 25, 2024.

What is the business address of Autolus Therapeutics plc?

The business address of Autolus Therapeutics plc is THE MEDIAWORKS, 191 WOOD LANE, LONDON, W12 7FP.

From the Filing

0001213900-24-090768.txt : 20241025 0001213900-24-090768.hdr.sgml : 20241025 20241025160119 ACCESSION NUMBER: 0001213900-24-090768 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20241025 DATE AS OF CHANGE: 20241025 GROUP MEMBERS: AMALAR HOLDING S.R.O. GROUP MEMBERS: PPF BIOTECH B.V. GROUP MEMBERS: RENATA KELLNEROVA SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Autolus Therapeutics plc CENTRAL INDEX KEY: 0001730463 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-90550 FILM NUMBER: 241397031 BUSINESS ADDRESS: STREET 1: THE MEDIAWORKS STREET 2: 191 WOOD LANE CITY: LONDON STATE: X0 ZIP: W12 7FP BUSINESS PHONE: 44 20 3829 6230 MAIL ADDRESS: STREET 1: THE MEDIAWORKS STREET 2: 191 WOOD LANE CITY: LONDON STATE: X0 ZIP: W12 7FP FORMER COMPANY: FORMER CONFORMED NAME: Autolus Therapeutics Ltd DATE OF NAME CHANGE: 20180205 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PPF Group N.V. CENTRAL INDEX KEY: 0001788137 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: STRAWINSKYLAAN 933 CITY: AMSTERDAM STATE: P7 ZIP: 1077XX BUSINESS PHONE: 31(0) 20 8813120 MAIL ADDRESS: STREET 1: STRAWINSKYLAAN 933 CITY: AMSTERDAM STATE: P7 ZIP: 1077XX SC 13D/A 1 ea0218619-13da10ppf_autolus.htm AMENDMENT NO. 10 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 10) AUTOLUS THERAPEUTICS PLC (Name of Issuer) American Depositary Shares, each representing one ordinary share, nominal value $0.000042 per share, and ordinary shares, nominal value $0.000042 per share (Title of Class of Securities) 05280R100** (CUSIP Number) c/o Lubomír Král PPF a.s. Evropská 2690/17 P.O. Box 177 160 41 Praha 6 Czech Republic Tel: (+420) 224 174 067 With copies to: Scott Levi White & Case LLP 1221 Avenue of the Americas New York, NY 10020-1095 +1 (212) 819 8200 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) October 24, 2024 (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐ Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. ** There is no CUSIP number assigned to the Ordinary Shares. CUSIP number 05280R100 has been assigned to the American Depositary Shares (“ADSs”) of the Company, which are quoted on the Nasdaq Global Select Market under the symbol “AUTL.” Each ADS represents 1 Ordinary Share. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 05280R100 1 NAME OF REPORTING PERSONS Renata Kellnerova 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☐ (b) ☐ 3 SEC USE ONLY 4 SOURCE OF FUNDS AF 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS I

View on Read The Filing